The demand for dermal fillers in Europe is set to experience steady growth, with projections indicating a 4.5% annual increase from 2023 to 2033. The market is estimated to be valued at approximately USD 1.63 billion in 2023, according to Future Market Insights.
The growth of the European dermal fillers market reflects a rising interest in cosmetic and aesthetic treatments, driven by increasing consumer awareness and demand for non-surgical solutions. Among the various ingredient types used in dermal fillers, Hyaluronic Acid continues to lead the market. In 2022, this ingredient held a substantial share of about 71.4% within the European market, underscoring its widespread acceptance and preference.
To create credibility and broaden the appeal of their products, manufacturers are increasingly concentrating on partnering with recognized cosmetic clinics and healthcare professionals in the aesthetic area. Joint marketing initiatives, educational initiatives, and exclusive distribution contracts are examples of partnerships.
Marketing and advertisement, advancing medical infrastructure as well as the rise in medical tourism in Europe are all such factors that are anticipated to grow the market of dermal fillers in Europe.
Europe Dermal Fillers Market Key Takeaways:
- By ingredient, the hyaluronic acid segment contributed around USD 1.1 Billion in 2022. Due to its great biocompatibility, versatility, and natural and long-lasting effects hyaluronic acid has been a constant favorite among consumers and practitioners.
- By product, absorbable dermal fillers contributed around USD 1.6 billion in 2022. Its high safety profile, natural-looking results and slow breakdown to avoid any sudden adverse change to the body are the major growth factors.
- By application, aesthetic restoration contributed around USD 1.3 billion in 2022, owing to the efficiency of dermal filler techniques in treating various aging symptoms and improving natural characteristics
- By end users, specialty clinics contributed around USD 1.4 billion in 2022, due to the increasing number of advanced clinics and customized treatment solutions
- By country, Germany held the dominant share in the world in 2022 with the U.S. contributing around 33.3% value share. Given its continuous technological improvements, rising aesthetic awareness, and advanced clinic infrastructure, Germany dominated the European dermal filler market.
Top 14 Key Players in Europe Dermal Fillers Market and Their Marketing Strategy
Key Players:
- Galderma Pharma S.A
- Bioscience GmbH
- Croman Pharma
- Allergan plc. (AbbVie)
- Sinclair Pharma plc. (Heading Medicine Co., Ltd)
- Zimmer Aesthetics
- Mars Pharma GmbH & Co. Kraal
- Zueva Medical, Inc.
- Texan Laboratories Inc.
- Adder GmbH
- Polonium Medical Technologies Inc.
- Intracellular Medical UK Ltd
- LKC Pharma
- Biloxi’s Pharmaceutical
The dermal filler market is moderately competitive in Europe. The market leaders are in a constant run to further establish their position by product launches and collaborations, which has inspired the upcoming players to follow their market footprints.
- In June 2023, Croma unveiled PhilArt, an extensive array of injectable skin enhancers. The injectable gel PhilArt, which is based on long-chain polynucleotides (PN), improves radiance via rejuvenation, restores the skin’s suppleness, encourages hydration and scavenges free radicals, fosters the formation of fibroblasts and fibers, and stimulates the body’s cell regeneration.
A Old Full Report Analysis Click Here
Europe Dermal Fillers Market Key Segments:
By Ingredient:
- Hyaluronic Acid
- Poly-L-Lactic Acid
- Calcium Hydroxylapatite
- Polymethyl methacrylate
- Collagen
- Polynucleotide (PN)
By Product Type:
- Absorbable
- Non-absorbable
By Application:
- Aesthetic Restoration
- Dentistry
- Reconstructive Surgery
By Distribution Channel:
- Hospitals
- Specialty Clinics
- Small
- Medium
- Large
- Online Pharmacies
By Country:
- United Kingdom
- Germany
- Spain
- Italy
- France
- BENELUX
- Nordics
- Rest of Europe
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube